Interleukin (IL)-6 as a pancreas carcinoma-derived vascular permeability regulator in vitro

Pathology Research and Practice

Volumn 192, Issue 11, 1996, Pages 1107-1112

  Omi, M ^a   Ishikura, H ^a   Ishizu, A ^a   Takahashi, T ^a   Kato, H ^a   Yoshiki, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Endothelial permeability; IL 6; Pancreas cancer

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CALMODULIN INHIBITOR; CYTOKINE; INTERLEUKIN 6; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PROTEIN KINASE INHIBITOR;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CULTURE; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; VASCULAR ENDOTHELIUM;

EID: 0030512673     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80027-6     Document Type: Article

References (27)

1. Brem H, Goto F, Budson A, Saunders L, Folkman J (1994) Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV:674-677
2. Campbell WC, Ding X, Goldblum SE (1992) Interleukin-1α and -ß augment pulmonary artery transendothelial albumin flux in vitro. Am J Physiol 263: L128-L136
3. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidiun thiocynate-phenol-chloroform extraction. Anal Biochem 162: 156-159
4. Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F (1991) Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood 78: 753-759
5. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109
6. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1: 27-31
7. Fu Y-X, Cai J-P, Chin Y-H, Watson GA, Lopez DM (1992) Regulation of leukocyte binding to endothelial tissues by tumor-derived GM-CSF. Int J Cancer 50: 585-588
8. Galo O, Bani D, Toccafondi G, Almerigogna F, Storchi OF (1992) Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor. Cancer 70: 559-568
9. Gitay-Goren H, Halaban R, Neufeld G (1993) Human melanoma cells but not normal melanocytes express vascular endothelial growth factor. Biochem Biophys Res Comm 190: 702-709
10. Gruss H-J, Brach MA, Mertelmann RH, Herrmann F (1991) Interferon-gamma interrupts autocrine growth mediated by endogenous interleukin-6 in renal cell carcinoma. Int J Cancer 49: 770-773
11. Ishizu A, Ishikura H, Nakamaru Y, Takeuchi E, Kimura C, Koike T, Yoshiki T (1995) Thy-1 induced on rat endothelium regulates vascular permeability at sites of inflammation. Int Immunol 7: 1939-1947
12. a in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer 54: 972-977
13. Kaji M, Ishikura H, Kishimoto T, Omi M, Ishizu A, Kimura C, Takahashi T, Kato H, Yoshiki T (1995) E-selectin expression induced by pancreas-carcinoma-derived interleukin-1α results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells. Int J Cancer 60: 712-717
14. Khawli LA, Miller GK, Epstein AL (1994) Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer 73: 824-831
15. Kirnbauer R, Koeck A, Schwars T, Urbanski A, Kurtmann J, Borth W (1989) B-cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 242: 1922-1928
16. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309
17. Levy Y, Tsapis A, Brouet J-C (1991) Interleukin-6 antisense oligonucleotides inhibits the growth of human myeloma cell lines. J Clin Invest 88: 696-699
18. Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131: 710-714
19. Motoyama T, Honma T, Watanabe H, Honma S, Kumanishi T, Abe S (1993) Interleukin 6-producing malignant mesothelioma. Virchows Archiv B Cell Pathol 64: 367-372
20. Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM (1992) Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased inmunogenicity, and decreased metastatic potential. Cancer Res 52: 6020-6024
21. Namba K, Otani T, Osada Y (1994) Enhancement of platelet recovery in X-irradiated guinea pigs by romurtide, a synthetic muramyl dipeptide derivative. Blood 83: 2480-2488
22. Ohe Y, Podack ER, Olsen KJ, Miyahara Y, Miura K, Saito H, Koishihara Y, Ohsugi Y, Ohira T, Nishio K, Saijo N (1993) Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shorten survival in syngeneic mice. Br J Cancer 67: 939-944
23. Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L (1992) Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52: 3679-3686
24. Renkonen R, Mennander A, Ustinov J, Matrila P (1990) Activation of protein kinase C is crucial in the regulation of ICAM-1 expression on endothelial cells by interferon-γ. Int Immunol 2: 719-724
25. Sugiura H, Ishikura H, Omi M, Kaji M, Iwai K, Kishimoto T, Takahashi T, Kimura C, Kato H, Yoshiki T (1994) Lymphokine-activated killer cytotoxicity against pancreas adenocarcinoma cell lines and vascular endothelial cells. Pathol Int 44: 688-696
26. Takahashi T, Ishikura H, Iwai K, Takahashi C, Kato H, Tanabe T, Yoshiki T (1993) Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro. Cancer Immunol Immunother 36: 76-82
27. Weinder N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. New Engl J Med 324: 1-8